PROPOFOL-LIPURO ® 10 mg/ml and 20 mg/ml

Propofol-®Lipuro is a highly innovative product from B. Braun’s unique Lipuro®-Technology, which uses MCT/LCT lipid emulsion as the drug delivery base with excellent solubility and stability.

The improved formulation entail

•  Significant reduction of injection pain
•  Reduction of lipid and fluid load
•  Optimized lipid metabolism
•  Maintenance of immune response
•  No negative effects on pulmonary function

The favorable properties of propofol in clinical use are given full scope, e.g.

• Rapid onset and short duration of effects
• Excellent control of anesthesia
• Outstanding safety
• Good tolerability

Presentaion

10 mg/ml ,50 ml Vial, and 20 ml Ampule
20mg/ml 50 ml Vial

Therapeutic indications for PROPOFOL- LIPURO® 10 mg/ml

Propofol-Lipuro 10mg/ml is a short-acting intravenous general anesthetic indicated for:

• Induction and maintenance of general anesthesia in adults and children over 1 month of age
• sedation of ventilated patients in the intensive care unit for adult over 16 years of age

• Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anesthesia for adults and children over 1 month of age

Therapeutic indications for PROPOFOL- LIPURO® 20 mg/ml

Propofol-Lipuro 20 mg/ml is a short-acting intravenous general anesthetic indicated for:

• Induction and maintenance of general anesthesia in adults and children over 3 years of age
• sedation of ventilated patients in the intensive care unit for adult over 16 years of age

• Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anesthesia for adults and children over 3 years of age